Preview

Epidemiology and Vaccinal Prevention

Advanced search

Outbreak of Andes Virus Infection on Board MV Hondius, April – May 2026: Lessons for Biosafety Preparedness

https://doi.org/10.31631/207330462026254414

Abstract

Relevance. In April 2026, an outbreak of hantavirus infection caused by Andes virus (Orthohantavirus andesense) was reported on the expedition vessel MV Hondius, which had departed from the port of Ushuaia, Argentina, on 1 April 2026. Clinical symptoms in the first affected passenger appeared on 6 April, and the patient died on board the vessel on 11 April. In the following weeks, severe cases were identified among passengers and crew members after some individuals had disembarked and subsequently travelled through several countries. Aim. To assess the epidemiological and genomic characteristics of the outbreak and identify lessons for biosafety systems. Materials and Methods. We analyzed data from the epidemiological investigation provided by WHO and national health authorities. Genomic sequencing was performed using metagenomic approaches, SISPA, and hybridization enrichment. Phylogenetic analysis was conducted using the maximum likelihood method in IQ-TREE 3. Results and Discussion. Following outbreak investigation and diagnostic testing of patients in different countries, a total of 13 cases of infection were identified including 11 laboratory-confirmed cases, 2 probable cases, and 3 deaths. The epidemiological investigation suggests primary zoonotic infection of the index patient before boarding the vessel in an endemic area of southern Argentina, followed by limited person-to-person transmission on board. Genomic analysis demonstrated a high degree of identity among viral sequences obtained from affected individuals, which is consistent with a single introduction followed by subsequent human-to-human transmission. Conclusions. The hantavirus outbreak on board MV Hondius represents an important example of an epidemiologically significant event in which a zoonotic pathogen with limited capacity for person-to-person transmission occurred within a closed international community. This event highlights the importance of early clinical diagnosis, sanitary and quarantine measures for contact persons, and rapid international exchange of genomic data to ensure biosafety during epidemic events caused by emerging, rare, or genetically altered pathogens.

About the Authors

V. G. Akimkin
Central Research Institute of Epidemiology of Rospotrebnadzor
Russian Federation

Vasily G. Akimkin – Academician of the Russian Academy of Sciences, Dr. Sci. (Med.), Professor, Director

Moscow



D. K. Lvov
Central Research Institute of Epidemiology of Rospotrebnadzor; D.I. Ivanovsky Institute of Virology of N.F. Gamaleya National Research Center for Epidemiology and Microbiology of the Ministry of Health of the Russian Federation
Russian Federation

Dmitry K. Lvov – Academician of the Russian Academy of Sciences, Dr. Sci. (Med.), Professor, Chief Researcher

Moscow



N. Yu. Pshenichnaya
Central Research Institute of Epidemiology of Rospotrebnadzor
Russian Federation

Natalia Yu. Pshenichnaya – Dr. Sci. (Med.), Professor, Deputy Director for Clinical and Analytical Work

Moscow



A. D. Muzyka
Central Research Institute of Epidemiology of Rospotrebnadzor
Russian Federation

Anna D. Muzyka – Cand. Sci. (Med.), Senior Researcher, Clinical Department of Infectious Pathology

Moscow



K. F. Khafizov
Central Research Institute of Epidemiology of Rospotrebnadzor
Russian Federation

Kamil F. Khafizov – Cand. Sci. (Biol.), Head, Laboratory for Genomic Research

Moscow



G. V. Roev
Central Research Institute of Epidemiology of Rospotrebnadzor; Moscow Institute of Physics and Technology
Russian Federation

German V. Roev – bioinformatician, Laboratory for Genomic Research

Moscow



M. R. Agletdinov
Central Research Institute of Epidemiology of Rospotrebnadzor
Russian Federation

Matvey R. Agletdinov – bioinformatician, Laboratory for Genomic Research

Moscow



A. A. Ploskireva
Central Research Institute of Epidemiology of Rospotrebnadzor
Russian Federation

Antonina A. Ploskireva – Dr. Sci. (Med.), Professor of the Russian Academy of Sciences, Deputy Director for Clinical Work

Moscow



E. S. Morozkin
Central Research Institute of Epidemiology of Rospotrebnadzor
Russian Federation

Evgeny S. Morozkin – Cand. Sci. (Chem.), Head, Research Group for the Development of New Diagnostic Methods for Natural Focal Diseases

Moscow



A. S. Cherkashina
Central Research Institute of Epidemiology of Rospotrebnadzor
Russian Federation

Anna S. Cherkashina – Cand. Sci. (Chem.), Head, Laboratory of Biotechnology and Molecular Biology

Moscow



E. A. Cherkashin
Central Research Institute of Epidemiology of Rospotrebnadzor
Russian Federation

Evgeny A. Cherkashin – Cand. Sci. (Chem.), Head, Center for Development, Product Development and Innovation

Moscow



G. A. Gasanov
Central Research Institute of Epidemiology of Rospotrebnadzor
Russian Federation

Gasan A. Gasanov – Cand. Sci. (Med.), Senior Researcher, Scientist, Laboratory of Molecular Epidemiology and Immunology

Moscow



A. S. Esman
Central Research Institute of Epidemiology of Rospotrebnadzor
Russian Federation

Anna S. Esman – Cand. Sci. (Med.), Head, Laboratory of Molecular Epidemiology and Immunology

Moscow



S. V. Alkhovsky
Central Research Institute of Epidemiology of Rospotrebnadzor; Medical and Biological University of Innovation and Continuing Education of the Federal Medical Biophysical Center named after A.I. Burnazyan FMBA of Russia
Russian Federation

Sergey V. Alkhovsky – Corresponding Member of the Russian Academy of Sciences, Dr. Sci. (Biol.), Advisor to the Director for Scientific Work in the Field  of Natural Focal and Emerging Infections

+7 (495) 672-10-69

3a Novogireevskaya str., Moscow, 111123



References

1. Lvov DK. Hemorrhagic fever with renal syndrome. In: Lvov DK, editor. Manual of Virology: Viruses and Viral Infections in Humans and Animals. Moscow: MIA; 2013. p. 797802. (In Russ.)

2. Lvov DK. Hantavirus cardiopulmonary syndrome. In: Lvov DK, editor. Manual of Virology: Viruses and Viral Infections in Humans and Animals. Moscow: MIA; 2013. p. 802–4. (In Russ.)

3. Young JC, Mills JN, Enria DA, Dolan NE, Khan AS, Ksiazek TG. New World hantaviruses. Br Med Bull. 1998;54(3):659–73. doi:10.1093/oxfordjournals.bmb.a011718

4. López N, Padula P, Rossi C, Lázaro ME, Franze-Fernández MT. Genetic identification of a new hantavirus causing severe pulmonary syndrome in Argentina. Virology. 1996;220(1):223–6. doi:10.1006/VIRO.1996.0305

5. Padula P, Della Valle MG, Alai MG, Cortada P, Villagra M, Gianella A. Andes virus and first case report of Bermejo virus causing fatal pulmonary syndrome. Emerg Infect Dis. 2002;8(4):437–9. doi:10.3201/eid0804.010300

6. Khan AS, Khabbaz RF, Armstrong LR, Holman RC, Bauer SP, Graber J, et al. Hantavirus pulmonary syndrome: The first 100 US cases. J Infect Dis. 1996;173(6):1297–303. doi:10.1093/INFDIS/173.6.1297

7. Martinez VP, Bellomo C, San Juan J, Pinna D, Forlenza R, Elder M, et al. Person-to-person transmission of Andes virus. Emerg Infect Dis. 2005;11(12):1848–53. doi:10.3201/EID1112.050501

8. Vitek CR, Breiman RF, Ksiazek TG, Rollin PE, McLaughlin JC, Umland ET, et al. Evidence against person-to-person transmission of hantavirus to health care workers. Clin Infect Dis. 1996;22(5):824–6.

9. Martinez-Valdebenito C, Calvo M, Vial C, Mansilla R, Marco C, Palma RE, et al. Person-to-person household and nosocomial transmission of Andes hantavirus, Southern Chile, 2011. Emerg Infect Dis. 2014;20(10):1629–36. doi:10.3201/eid2010.140353

10. Padula PJ, Edelstein A, Miguel SD, Lopez NM, Rossi CM, Rabinovich RD. Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus. Virology. 1998;241(2):323–30. doi:10.1006/viro.1997.8976

11. Bradfute SB, Calisher CH, Klempa B, Klingström J, Kuhn JH, Laenen L, et al. ICTV Virus Taxonomy Profile: Hantaviridae 2024. J Gen Virol. 2024;105(4). doi:10.1099/JGV.0.001975

12. Lednicky JA. Hantaviruses. A short review. Arch Pathol Lab Med. 2003;127(1):30–5. doi:10.1043/0003-9985(2003)127<30:>2.0.CO;2

13. Simmons JH, Riley LK. Hantaviruses: an overview. Comp Med. 2002;52(2):97–110.

14. Johnson KM. Hantaviruses: history and overview. Curr Top Microbiol Immunol. 2001;256:1–14.

15. Tkachenko EA, Dzagurova TK, Tkachenko PE. Hantaviruses: ecology, molecular biology, morphology, pathogenesis and diagnostics of hantavirus infections. Molekulyarnaya Meditsina. 2009;(5):36–41. (In Russ.)

16. Lvov DK, Shchelkanov MY, Alkhovsky SV, Deryabin PG. Zoonotic viruses of Northern Eurasia: Taxonomy and ecology. London: Academic Press, Elsevier; 2015. 440 p.

17. Yashina L, Mishin V, Zdanovskaya N, Schmaljohn C, Ivanov L. A newly discovered variant of a hantavirus in Apodemus peninsulae, far Eastern Russia. Emerg Infect Dis. 2001;7(5):912–3. doi:10.3201/eid0705.017530

18. Yashina LN, Abramov SA, Gutorov VV, Dupal TA, Krivopalov AV, Panov VV, et al. Seewis virus: phylogeography of a shrew-borne hantavirus in Siberia, Russia. Vector Borne Zoonotic Dis. 2010;10(6):585–91. doi:10.1089/vbz.2009.0154

19. Astorga F, Escobar LE, Poo-Muñoz D, Escobar-Dodero J, Rojas-Hucks S, Alvarado-Rybak M, et al. Distributional ecology of Andes hantavirus: A macroecological approach. Int J Health Geogr. 2018;17(1). doi:10.1186/s12942-018-0142-z

20. Medina RA, Torres-Perez F, Galeno H, Navarrete M, Vial PA, Palma RE, et al. Ecology, genetic diversity, and phylogeographic structure of Andes virus in humans and rodents in Chile. J Virol. 2009;83(6):2446–59. doi:10.1128/JVI.01057-08

21. Carbajo AE, Vera C, Gonzalez PL. Hantavirus reservoir Oligoryzomys longicaudatus spatial distribution sensitivity to climate change scenarios in Argentine Patagonia. Int J Health Geogr. 2009;8:44. doi:10.1186/1476-072X-8-44

22. Andreo V, Glass G, Shields T, Provensal C, Polop J. Modeling potential distribution of Oligoryzomys longicaudatus, the Andes virus (Genus: Hantavirus) reservoir, in Argentina. Ecohealth. 2011;8(3):332–48. doi:10.1007/s10393-011-0719-5

23. Pizarro E, Navarrete M, Mendez C, Zaror L, Mansilla C, Tapia M, et al. Immunocytochemical and ultrastructural evidence supporting that Andes hantavirus (ANDV) is transmitted person-to-person through the respiratory and/or salivary pathways. Front Microbiol. 2020;10:2992. doi:10.3389/FMICB.2019.02992

24. Markotić A. Presence of Andes orthohantavirus in human body fluids. Lancet Infect Dis. 2024;24(7):674–6. doi:10.1016/S1473-3099(24)00172-5

25. Martínez VP, Di Paola N, Alonso DO, Pérez-Sautu U, Bellomo CM, Iglesias AA, et al. «Super-Spreaders» and person-to-person transmission of Andes virus in Argentina. N Engl J Med. 2020;383(23):2230–41. doi:10.1056/NEJMOA2009040

26. Wong TKF, Ly-Trong N, Ren H, Demotte P, Baños H, Roger AJ, et al. IQ-TREE 3: phylogenomic inference software using complex evolutionary models. Mol Biol Evol. 2026;43(5). doi:10.1093/molbev/msag117

27. Pathoplexus. SeqSet: Andes. 2026. doi:10.62599/PP_SS_2476.1. Available at: https://pathoplexus.org/seqsets/PP_SS_2476.1. Accessed: 22 May 2026.


Review

For citations:


Akimkin V.G., Lvov D.K., Pshenichnaya N.Yu., Muzyka A.D., Khafizov K.F., Roev G.V., Agletdinov M.R., Ploskireva A.A., Morozkin E.S., Cherkashina A.S., Cherkashin E.A., Gasanov G.A., Esman A.S., Alkhovsky S.V. Outbreak of Andes Virus Infection on Board MV Hondius, April – May 2026: Lessons for Biosafety Preparedness. Epidemiology and Vaccinal Prevention. 2026;25(4):4-14. (In Russ.) https://doi.org/10.31631/207330462026254414

Views: 484

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2073-3046 (Print)
ISSN 2619-0494 (Online)